Glycine, a simple amino acid, has emerged as a potential geroprotector with promising effects on lifespan and healthspan in various model organisms. Recent studies suggest that glycine supplementation may offer anti-inflammatory and metabolic benefits in humans, sparking interest in its potential to prevent, delay, or reverse aspects of the aging process.

Lifespan Extension in Model Organisms

Model organisms like yeast, nematodes, fruit flies, and mice have been instrumental in identifying genes and pathways that influence longevity. Researchers have achieved significant lifespan extensions in these organisms through genetic manipulation and interventions like calorie restriction[1][2]. For example, mutations in the insulin/insulin-like growth factor signaling pathway can extend lifespan across multiple species[5]. However, translating these findings to humans remains challenging due to fundamental differences in aging processes between short-lived model organisms and humans[2]. While model organisms don't develop many age-related diseases seen in humans, they provide valuable insights into conserved aging mechanisms that may be relevant to human longevity[1][4]. Ongoing research aims to bridge this gap, potentially through computational models that can be "humanized" to better predict effects in humans[2].

Sources: [1]     [2]     [3]     [4]     [5]

NMDA Receptor Modulation

NMDA receptors (NMDARs) are glutamate-gated ion channels that play crucial roles in synaptic transmission and plasticity. Both hyper- and hypo-activation of NMDARs can be detrimental to neuronal function, with NMDAR hypofunction implicated in various neurological and psychiatric conditions such as schizophrenia, intellectual disability, and Alzheimer's disease[1][2]. Recent research has focused on developing NMDAR positive allosteric modulators (PAMs) to address NMDAR hypofunction[2]. These PAMs offer potential therapeutic benefits for cognitive enhancement and treatment of disorders associated with NMDAR dysfunction[2][4]. However, the complexity of NMDAR function and the potential risks of modulation necessitate careful consideration in developing these agents for clinical use[4]. Ongoing studies are exploring subunit-selective modulators to target specific NMDAR subtypes, which may allow for more precise circuit modification and potentially lead to new treatments for a range of neuropsychiatric conditions[4].

Sources: [1]     [2]     [3]     [4]     [5]

Effects on Sleep Quality

Glycine supplementation has shown promising effects on sleep quality in both healthy individuals and those experiencing sleep disturbances. Studies have demonstrated that ingesting 3 grams of glycine before bedtime can improve subjective sleep quality, reduce sleep latency, and enhance sleep efficacy[1][2]. Participants reported feeling more alert and less fatigued during the day following glycine supplementation[3]. The amino acid's sleep-promoting effects are thought to be mediated through its action on NMDA receptors in the suprachiasmatic nucleus, which regulates circadian rhythms[5]. Glycine may also improve sleep by lowering core body temperature, facilitating the onset of sleep[4]. These benefits were observed not only in individuals with mild insomnia but also in those experiencing occasional sleep restrictions, suggesting glycine's potential as a natural sleep aid for various populations[3][5].

Sources: [1]     [2]     [3]     [4]     [5]

Share this post